Financials ContraFect Corporation

Equities

CFRXQ

US2123264093

Biotechnology & Medical Research

Market Closed - OTC Markets 10:35:19 2024-04-26 am EDT 5-day change 1st Jan Change
0.018 USD 0.00% Intraday chart for ContraFect Corporation -16.67% -40.00%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 121.5 95.17 140.4 103.4 4.194 0.1927 0.1927 -
Enterprise Value (EV) 1 121.5 95.17 140.4 103.4 4.194 0.1927 0.1927 0.1927
P/E ratio -3.06 x -4.03 x -4.07 x -4.78 x -0.06 x -0.01 x -0.01 x -0.02 x
Yield - - - - - - - -
Capitalization / Revenue - - - - - - - -
EV / Revenue - - - - - - - -
EV / EBITDA - - -4,121,966 x -2,195,493 x - - - -
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 99.3 192 348 492 546 10,705 10,705 -
Reference price 2 1,224 496.6 404.0 210.4 7.680 0.0180 0.0180 0.0180
Announcement Date 3/14/19 3/18/20 3/30/21 3/24/22 3/31/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 - - - - - - - -
EBITDA - - -34.07 -47.12 - - - -
EBIT 1 -31.12 -27.87 -34.24 -47.26 -56.89 -31.3 -30 -33.4
Operating Margin - - - - - - - -
Earnings before Tax (EBT) 1 -37.68 -12.79 -28.16 -20.28 -65.15 -23.4 -30 -33.4
Net income 1 -37.68 -12.79 -28.16 -20.28 -65.15 -23.4 -30 -33.4
Net margin - - - - - - - -
EPS 2 -400.0 -123.2 -99.20 -44.00 -125.0 -3.440 -1.500 -1.110
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 3/14/19 3/18/20 3/30/21 3/24/22 3/31/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 - - - - - - - - - - -
EBITDA - - - - - - - - - - -
EBIT 1 -10.71 -11.69 -14.08 -15.98 -20.03 -14.18 -6.703 -8.858 -7.975 -6.677 -7.4
Operating Margin - - - - - - - - - - -
Earnings before Tax (EBT) 1 -5.396 -5.292 -4.399 -20.16 -18.09 -17.07 -9.839 -1.371 -7.568 -5.359 -7.4
Net income 1 -5.396 -5.292 -4.399 -20.16 -18.09 -17.07 -9.839 -1.371 -7.568 -5.359 -7.4
Net margin - - - - - - - - - - -
EPS 2 -11.20 -10.40 -8.800 -40.80 -36.80 -34.40 -16.14 -0.6900 -1.940 -0.5000 -0.6900
Dividend per Share - - - - - - - - - - -
Announcement Date 8/13/21 11/15/21 3/24/22 5/16/22 8/15/22 11/14/22 3/31/23 5/15/23 8/14/23 11/14/23 -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 3/14/19 3/18/20 3/30/21 3/24/22 3/31/23 - - -
1USD in Million
Estimates
  1. Stock Market
  2. Equities
  3. CFRXQ Stock
  4. Financials ContraFect Corporation